„BCRT – Your Strategic Partner in Regenerative Medicine”

17.03.2010, 1:00 – 3:00 pm., at Charité Entrepreneurship Summit (Forum 3, 2nd floor at Charité Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin)

Lowering the entry risks for co-development partners

Chair: Dr. Frank-Roman Lauter (Head of Business Development BCRT)

Registration Form

Time Title Speaker
1:00 – 1:05 p.m. Qualified co-development - screening the opportunities Dr. Frank-Roman Lauter - Head of Business Development BCRT
1:05 – 1:15 p.m. The Berlin-Brandenburg Center for Regenerative Therapies Prof. Hans-Dieter Volk - Director of Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
1:15 – 1:30 p.m. Generation of qualified product candidates – Opportunity Check – Dr. Frank-Roman Lauter - Head of Business Development BCRT
1:30 – 1:40 p.m. The efficient way into the clinic – Regulatory Check – Dr. Barbara Pfüller - Head of Clinical Development & Regulatory Affairs BCRT
1:40 – 2:00 p.m. Example: development of a product candidate Prof. Georg Duda - Vice-Director of Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
2:00 – 2:20 p.m. Example: clinical realization of a cell-based therapy Prof. Petra Reinke - Platform leader “Immunology” BCRT, Charité Dept. Nephrology and Internal Intensive Care, Medical Director Kidney Transplant Program
2:20 – 2:40 p.m. Example: Pluristem Inc. – an industrial co-development project Mr. Thomas Klein - Legal Representative of Pluristem Inc. PLX-PAD Clinical Study
2:40-2:50 p.m. Models to work with translational centers Mr. Gregory Bonfiglio - Managing Partner of Proteus Venture Partners Inc.
2:50 – 3:00 p.m. Discussion Moderation of Dr. Lauter - Head of Business Development BCRT

contact:

Ms Ina Krueger
ina.krueger@b-crt.de
+49 30 450 539 416

Speakers

  • Duda, Georg N.: Vice-Director of Berlin-Brandenburg Center for Regenerative Therapies, Berlin/ Germany

  • Klein, Thomas, Legal Representative of Pluristem Inc. PLX-PAD Clinical Study

  • Lauter, Frank-Roman: Entrepreneur, Head Business Development Berlin-Brandenburg Center for Regenerative Therapies, Berlin/Germany

  • Pfueller, Barbara Head Clinical Development & Regulatory Affairs, Berlin-Brandenburg Center for Regenerative Therapies, Berlin/ Germany

  • Reinke, Petra, Medical Director of the Kidney Transplant Program and platform leader for immunology and cell therapy at the BCRT

  • Volk, Hans-Dieter: Director of Berlin-Brandenburg Center for Regenerative Therapies, Berlin/ Germany

The Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is responsible for the programme of this module and for the contents of this page.